Atlas Trials

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children

Clinical trial NCT02383108 · COMPLETED

Trial details

NCT number
NCT02383108
Sponsor
PENTA Foundation
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV Infection
Start date
2016-06-01
Primary completion
2020-08-01
Enrollment
318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.